NSE List Price : ₹111.00

subscription

Category	Times
QIBs	21.05x
HNIs	24.62x
Retail	20.08x
Total : 22.39x

IPO Market Lot(s) Distribution

Application	Lot Size	Shares	Amount
Retail Minimum	2	2,400	₹259,200
Retail Maximum	2	2,400	₹259,200
S-HNI Minimum	3	3,600	₹388,800
S-HNI Maximum	7	8,400	₹907,200
B-HNI Minimum	8	9,600	₹1,036,800

About the Company

Established in 2023, Biopal Chemicals operates in the manufacturing and distribution of specialty chemicals, including silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s portfolio comprises around 40 silicone-based products, 5 emulsifier products, 15 biochemical products, and 6 polyelectrolyte products.

Its offerings cater to a wide range of industries such as textiles, home care, agriculture, and industrial chemicals. Biopal Chemicals runs four manufacturing units located in Gujarat and West Bengal, with an annual production capacity of approximately 18,25,000 litres. In addition to product manufacturing, the company also offers technical consultancy support to its customers. The business follows a B2B operating model, serving institutional clients rather than the retail segment.

Company Financial Report

_{Amount ₹ in Crores}

Period Ended	Revenue	Expense	PAT	Assets
2024	₹17.43	₹15.72	₹2.96	₹17.56
2025	₹49.15	₹43.35	₹4.33	₹31.48
Dec 2025	₹48.97	₹40.89	₹6.00	₹48.88

Company Promoter

Mr. Santanu Sarkar

Mr. Vedant Sarkar

Know before investing

• • Strengths

  Integrated Manufacturing Facility: The company operates a fully integrated and well-equipped manufacturing unit in West Bengal with an annual installed capacity of 18.25 lakh litres. The facility is supported by advanced infrastructure, including reactors, mixers, homogenizers, and blending equipment, ensuring efficient and streamlined production of specialty chemicals.

  Strategic Regional Presence: The company derives a significant portion of its revenues from West Bengal and Gujarat, with these regions consistently accounting for the majority of total income in recent financial periods, thereby enhancing operational stability and strengthening market reach.

• • Risks

  Expansion & Execution Risk: The planned expansion in Gujarat, involving the acquisition of industrial land and augmentation of capacity, requires substantial capital outlay and is dependent on timely regulatory approvals, construction, commissioning, and availability of skilled manpower. Any delays, cost escalations, or inability to realize anticipated operational efficiencies could negatively affect the company’s operations and profitability.

  Leased Premises Risk: The company conducts all its manufacturing, office, and warehousing activities from leased and unregistered premises. Any cancellation, non-renewal, escalation in rental costs, or unfavorable changes in lease conditions may disrupt operations, lead to higher expenses, or necessitate relocation, thereby affecting business continuity.

Objects of the Issue & Utilisation of proceeds

Acquisition of industrial land.
Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies.
General Corporate Purpose.

Company  Address

Biopol Chemicals Ltd
D-211, 2nd Floor, Block-D,
Sumel Business Park-6 Near Dudheshwar Circle
Dudheshwar Tavdipura
Ahmedabad, Gujarat, 380004
Phone: +91- 9147076778
Email: investors@biopolchemicals.com
Website: https://biopolchemicals.com/

IPO Registrar

Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html